Clinical Trial Update: Safety Study of Autologous Stem Cell in Liver Cirrhosis [Phase 1, Phase 2]

View source ↗

Summary

A safety-focused Phase 1/Phase 2 clinical trial evaluating autologous stem cell therapy for liver cirrhosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• Autologous stem cell therapy

Snippet

Sponsor: Universidade Federal do Rio de Janeiro | Conditions: Liver Cirrhosis | Phase 1, Phase 2 | Status: TERMINATED